Nephrotic Syndrome

• FDA label_change · 2015-03-30
  FDA Approved: EDECRIN — Supplemental Application (Bausch Health US, LLC)

  FDA approved a supplemental application for EDECRIN (ethacrynic acid) submitted by Bausch Health US, LLC, updating the drug's labeling.

• FDA label_change · 2012-07-11
  FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for furosemide from Chartwell RX, LLC, resulting in changes to the drug's labeling.